These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11197742)

  • 1. Apligraf--a living human skin equivalent for the treatment of chronic wounds.
    Streit M; Braathen LR
    Int J Artif Organs; 2000 Dec; 23(12):831-3. PubMed ID: 11197742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.
    Zaulyanov L; Kirsner RS
    Clin Interv Aging; 2007; 2(1):93-8. PubMed ID: 18044080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.
    Trent JF; Kirsner RS
    Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Apligraf in the treatment of venous leg ulcers.
    Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
    Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
    Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
    Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
    Karr J
    Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Apligraf in acute wounds.
    Kirsner RS
    J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery.
    Gohari S; Gambla C; Healey M; Spaulding G; Gordon KB; Swan J; Cook B; West DP; Lapiere JC
    Dermatol Surg; 2002 Dec; 28(12):1107-14; discussion 1114. PubMed ID: 12472488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Prospective, Blinded-Enrollment, Head-To-Head Venous Leg Ulcer Healing Trial Comparing Living, Bioengineered Skin Graft Substitute (Apligraf) with Living, Cryopreserved, Human Skin Allograft (TheraSkin).
    Towler MA; Rush EW; Richardson MK; Williams CL
    Clin Podiatr Med Surg; 2018 Jul; 35(3):357-365. PubMed ID: 29861018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers.
    Fivenson D; Scherschun L
    Int J Dermatol; 2003 Dec; 42(12):960-5. PubMed ID: 14636194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative therapies in wound healing.
    Shen JT; Falanga V
    J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with a new human skin equivalent for healing venous leg ulcers.
    Fahey C
    J Vasc Nurs; 1998 Mar; 16(1):11-5. PubMed ID: 9764027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatments in ulcer healing and wound infection.
    Edmonds M; Bates M; Doxford M; Gough A; Foster A
    Diabetes Metab Res Rev; 2000; 16 Suppl 1():S51-4. PubMed ID: 11054889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcers associated with polyarteritis nodosa treated with bioengineered human skin equivalent (Apligraf).
    Pennoyer JW; Susser WS; Chapman MS
    J Am Acad Dermatol; 2002 Jan; 46(1):145. PubMed ID: 11756967
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin ulcers in lower extremities: the epidemiology and management in China.
    Fu X
    Int J Low Extrem Wounds; 2005 Mar; 4(1):4-6. PubMed ID: 15860446
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel treatment for venous leg ulcers.
    Alvarez OM; Fahey CB; Auletta MJ; Fernández-Obregón A
    J Foot Ankle Surg; 1998; 37(4):319-24. PubMed ID: 9710785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin substitutes to enhance wound healing.
    Mansbridge J
    Expert Opin Investig Drugs; 1998 May; 7(5):803-9. PubMed ID: 15991970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.